Role of Angiotensin Converting Enzyme in Development of Diabetic Nephropathy | ||||
| Suez Canal University Medical Journal | ||||
| Article 1, Volume 27, Issue 12, December 2024, Page 1-6 PDF (234.88 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/scumj.2024.397936 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Shrouq Tolba1; Ahmed Mossad 2; Nashwa Ramadan Hassan  1; Mohamed Osama1; Ola F. Leheta 1
| ||||
| 1Department of Clinical and Chemical Pathology, Faculty of Medicine, Suez Canal University, Egypt. | ||||
| 2Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Egypt | ||||
| Abstract | ||||
| Background:Diabetic Nephropathy (DN) is one of the most serious microvascular complications and its pathogenesis involves a complex interplay between metabolic and hemodynamic factors interacting through molecular and signaling pathways with growing evidence indicating that the chronic activation of renal and systemic angiotensin-converting enzyme (ACE) is considered a key factor in the pathogenesis of DN. Objectives: This study aimed to investigate the association between serum ACE levels in the development of DN in patients with type 2 diabetes mellitus (T2DM) in the Egyptian population. Methods: a case-control study enrolled 90 subjects divided into three groups: 30 diabetic patients without DN, 30 diabetic patients with DN, and 30 healthy individuals as a control group. We measured for each patient the following: serum creatinine, estimated Glomerular filtration rate (eGFR), Albumin-to creatinine ratio (ACR), as well as serum ACE level. Results: serum ACE level showed that there was a statistically significant difference between diabetic patients with the nephropathy group and the other study groups. Conclusion: Our findings indicate that serum ACE level could be a risk factor for DN among the Egyptian population. | ||||
| Keywords | ||||
| ACE level; Diabetic Nephropathy; Angiotensin | ||||
|
Statistics Article View: 36 PDF Download: 71 |
||||
